Cystaran (cysteamine ophthalmic solution)
Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.
Most common reason: Wrong potency / content (3 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Cysteamine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.
Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride.
Subpotent Drug: Out of specification for an active ingredient cysteamine hydrochloride.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.